Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Por um escritor misterioso
Descrição
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
WO2014033122A1 - Inhibitors of cd40-traf6 interaction - Google Patents
Directing the Metabolism of Drugs Away from CYP450: The Use of Oxetane Rings
Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction
Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics - ScienceDirect
PDF) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics - ScienceDirect
Feng Ren LinkedIn
WO2014033122A1 - Inhibitors of cd40-traf6 interaction - Google Patents
Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
